No increase in cerebrospinal fluid tau protein levels in patients with vascular dementia

被引:41
作者
Arai, H [1 ]
Satoh-Nakagawa, T
Higuchi, M
Morikawa, Y
Miura, M
Kawakami, H
Seki, H
Takase, S
Sasaki, H
机构
[1] Tohoku Univ, Sch Med, Dept Geriatr Med, Sendai, Miyagi 9808574, Japan
[2] Mitsubishi Kagaku Bioclin Labs, Dept Res & Dev, Tokyo 114, Japan
[3] Kohnan Hosp, Dept Neurol, Sendai, Miyagi 980, Japan
关键词
vascular dementia; Alzheimer's disease; cerebrospinal fluid; tau protein; cerebrovascular disease; biological marker;
D O I
10.1016/S0304-3940(98)00781-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Tau protein levels in cerebrospinal fluid (CSF-tau) were determined in 29 patients with old cerebrovascular disease (CVD, 21 demented and eight non-demented), 69 patients with Alzheimer's disease (AD) and 17 age-matched normal controls. The CSF tau level in the vascular dementia (VD) group (24.0 +/- 17.0 pg/ml) was significantly lower (P < 0.0001) than that in the AD group (90.0 +/- 45.3 pg/ml), but not significantly different from that in the non-demented patients with CVD (18.1 +/- 10.2 pg/ml) or controls (20.3 +/- 13.0 pg/ml). Among the VD patients, 1/21 exceeded a cut-off value (mean +/- 2 SD of controls), whereas 8/69 of the AD patients had CSF-tau levels below this value. These findings suggest that VD constitutes a group of dementias that can be separated from AD by normal CSF-tau levels. CSF-tau determinations in combination with other clinical findings may provide another diagnostic aid in the differential diagnosis between VD and AD. (C) 1998 Elsevier Science ireland Ltd. All rights reserved.
引用
收藏
页码:174 / 176
页数:3
相关论文
共 13 条
[1]  
Alzheimers Assoc, 1998, NEUROBIOL AGING, V19, P109
[2]   Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease:: a community based follow up study [J].
Andreasen, N ;
Vanmechelen, E ;
Van de Voorde, A ;
Davidsson, P ;
Hesse, C ;
Tarvonen, S ;
Räihä, I ;
Sourander, L ;
Winblad, B ;
Blennow, K .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (03) :298-305
[3]   TAU IN CEREBROSPINAL-FLUID - A POTENTIAL DIAGNOSTIC MARKER IN ALZHEIMERS-DISEASE [J].
ARAI, H ;
TERAJIMA, M ;
MIURA, L ;
HIGUCHI, S ;
MURAMATSU, T ;
MACHIDA, N ;
SEIKI, H ;
TAKASE, S ;
CLARK, CM ;
LEE, VMY ;
TROJANOWSKI, JQ ;
SASAKI, H .
ANNALS OF NEUROLOGY, 1995, 38 (04) :649-652
[4]  
Blennow K, 1994, Int Psychogeriatr, V6, P13, DOI 10.1017/S1041610294001584
[5]   CRITERIA FOR THE DIAGNOSIS OF ISCHEMIC VASCULAR DEMENTIA PROPOSED BY THE STATE OF CALIFORNIA ALZHEIMERS-DISEASE-DIAGNOSTIC-AND-TREATMENT-CENTERS [J].
CHUI, HC ;
VICTOROFF, JI ;
MARGOLIN, D ;
JAGUST, W ;
SHANKLE, R ;
KATZMAN, R .
NEUROLOGY, 1992, 42 (03) :473-480
[6]   SULFATIDE AS A BIOCHEMICAL MARKER IN CEREBROSPINAL-FLUID OF PATIENTS WITH VASCULAR DEMENTIA [J].
FREDMAN, P ;
WALLIN, A ;
BLENNOW, K ;
DAVIDSSON, P ;
GOTTFRIES, CG ;
SVENNERHOLM, L .
ACTA NEUROLOGICA SCANDINAVICA, 1992, 85 (02) :103-106
[7]   Vascular dementia: Still a debatable entity? [J].
Loeb, C ;
Meyer, JS .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1996, 143 (1-2) :31-40
[8]  
MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
[9]   Disturbed consciousness and asthma [J].
Ohrui, T ;
Yamaya, M ;
Arai, H ;
Sekizawa, K ;
Sasaki, H .
LANCET, 1997, 349 (9052) :652-652
[10]   A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: Relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele [J].
Skoog, I ;
Vanmechelen, E ;
Andreasson, LA ;
Palmertz, B ;
Davidsson, P ;
Hesse, C ;
Blennow, K .
NEURODEGENERATION, 1995, 4 (04) :433-442